Private Firms Rake in £1.6bn Profits from NHS Contracts, MPs Label It 'Scandalous'
Private companies delivering services to the National Health Service have generated a staggering £1.6 billion in profits over the past two years, according to exclusive research. The findings, based on contracts worth £12 billion, have ignited fierce criticism from MPs who describe the profit-making levels as 'scandalous' and are urging ministers to impose a strict cap on the amount private entities can earn from NHS work.
Profits Equivalent to Funding Thousands of Healthcare Staff
The £1.6 billion in profits accrued during 2023-24 and 2024-25 would have been sufficient to pay for 9,178 doctors or 19,428 nurses over the same period, as highlighted by the Centre for Health and the Public Interest (CHPI). This analysis stems from a detailed review of NHS contracts in England, involving 760 private firms that provide a range of services, including diagnostic tests like CT scans, treatments for hip and knee replacements, and care for skin conditions and mental health issues.
Key revelations from the CHPI report include:
- £2 billion of the £12 billion in contracts were awarded to firms with owners based outside the United Kingdom.
- £533 million of that £2 billion went to companies owned by individuals residing in tax havens such as Jersey and the Cayman Islands.
- Private firms, particularly those owned by private equity groups, utilized £353 million of their NHS income to cover interest payments on debts.
Political Outcry and Calls for Immediate Action
Helen Morgan, the Liberal Democrats' health spokesperson, condemned the situation, stating, 'Private companies making super-profits from our NHS is an unacceptable waste. This money should be directed toward frontline services, not used to inflate profits for large corporations. The NHS should leverage its purchasing power to secure better deals, but it appears the health service is being exploited.'
Labour MP Stella Creasy echoed these concerns, adding, 'It is frankly scandalous that while patients endure long waiting times for operations, taxpayer funds are being diverted to offshore tax havens and private equity pockets through excessive profits. We urgently need a cap on this profiteering and full transparency on where this money ultimately ends up.'
Detailed Breakdown of High-Profit Firms
The CHPI's analysis did not disclose the names of all 760 companies involved, but separate research identified 28 firms that earn over £5 million annually from the NHS, achieve profit margins of at least 17%, and collectively received £4.1 billion in the last two years. These entities include major private healthcare providers like Spire and Circle, consultancy giants such as PricewaterhouseCoopers and PA Consulting, as well as specialists in eyesight treatment, diagnostic tests, technology, IT, and electronic patient records.
Proposals for Reform and Industry Response
David Rowland, director of the CHPI, has called on the government to implement a profit cap for firms servicing the NHS, modeled after the 8% limit being legislated for children's social care providers. He argued that existing caps on profits for drug and defense firms in public contracts demonstrate the feasibility of such a system for the NHS.
In contrast, the Independent Healthcare Providers Network, representing non-NHS healthcare operators, expressed skepticism about the CHPI's conclusions. A spokesperson remarked, 'Headline figures like this risk oversimplifying a complex scenario. The analysis merges various companies contracted by the NHS, not solely those involved in patient care, and employs a rudimentary method to estimate profit based on overall company data that does not differentiate between NHS and private work. Independent providers are crucial in delivering care to millions of NHS patients annually, and any surplus reflects efficiency, enabling reinvestment in staff, facilities, and services to benefit patients and reduce waiting times.'
Government Stance and Future Implications
The Department of Health and Social Care defended the NHS's engagement with private firms, with a spokesperson noting, 'The independent sector plays a role in addressing waiting list backlogs and fostering a sustainable health system. However, we will not tolerate any manipulation of payment systems to select only profitable cases or any compromises in quality. All care commissioned from independent providers must adhere to NHS standards.'
This report underscores ongoing debates about privatization, profit margins, and the allocation of public funds within the UK's healthcare system, highlighting the urgent need for policy adjustments to ensure taxpayer money is used effectively for patient care.
